Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
Subst Abus
; 41(2): 147-149, 2020.
Article
in English
| MEDLINE | ID: covidwho-104139
ABSTRACT
We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Continuity of Patient Care
/
Opioid-Related Disorders
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Subst Abus
Journal subject:
Substance-Related Disorders
Year:
2020
Document Type:
Article
Affiliation country:
08897077.2020.1752351
Similar
MEDLINE
...
LILACS
LIS